Editorial: 5-aminosalicylic acid fails to impact on irritable bowel syndrome—wrong population, intervention, target or hypothesis?

Research output: Contribution to journalEditorialpeer-review

Original languageEnglish (US)
Pages (from-to)1497-1498
Number of pages2
JournalAlimentary Pharmacology and Therapeutics
Volume56
Issue number10
DOIs
StatePublished - Nov 2022

Keywords

  • Humans
  • Irritable Bowel Syndrome/drug therapy
  • Mesalamine/therapeutic use
  • Surveys and Questionnaires
  • Quality of Life

ASJC Scopus subject areas

  • Gastroenterology
  • Pharmacology (medical)
  • Hepatology

Cite this